First Therapeutic Vaccine for Genital Herpes Reduces Signs of Infection for One Year
JUN 22, 2016 | SARAH ANWAR
The only treatments currently available to those who suffer from genital herpes consist of antiviral medications aimed at treating and limiting acute lesion outbreaks and reducing the risk of sexually transmitting herpes simplex 2 (HSV-2). In the future, GEN-003 will be tested as a combination therapy with antiviral medications.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512